Merlo Sebastjan, Starčević Jovana Nikolajević, Mankoč Sara, Šantl Letonja Marija, Cokan Vujkovac Andreja, Zorc Marjeta, Petrovič Daniel
Institute of Oncology Ljubljana, Zaloška 2, Sl-1000 Ljubljana, Slovenia.
Institute of Histology and Embryology, Faculty of Medicine, University in Ljubljana, Vrazov trg 2, Sl-1000 Ljubljana, Slovenia.
J Diabetes Res. 2016;2016:1482194. doi: 10.1155/2016/1482194. Epub 2015 Dec 31.
Background. The current study was designed to reveal possible associations between the polymorphisms of the vascular endothelial growth factor (VEGF) gene (rs2010963) and its receptor, kinase insert domain-containing receptor (KDR) gene polymorphism (rs2071559), and markers of carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM). Patients and Methods. 595 T2DM subjects and 200 control subjects were enrolled. The carotid intima-media thickness (CIMT) and plaque characteristics (presence and structure) were assessed ultrasonographically. Biochemical analyses were performed using standard biochemical methods. Genotyping of VEGF/KDR polymorphisms (rs2010963, rs2071559) was performed using KASPar assays. Results. Genotype distributions and allele frequencies of the VEGF/KDR polymorphisms (rs2010963, rs2071559) were not statistically significantly different between diabetic patients and controls. In our study, we demonstrated an association between the rs2071559 of KDR and either CIMT or the sum of plaque thickness in subjects with T2DM. We did not, however, demonstrate any association between the tested polymorphism of VEGF (rs2010963) and either CIMT, the sum of plaque thickness, the number of involved segments, hsCRP, the presence of carotid plaques, or the presence of unstable carotid plaques. Conclusions. In the present study, we demonstrated minor effect of the rs2071559 of KDR on markers of carotid atherosclerosis in subjects with T2DM.
背景。本研究旨在揭示血管内皮生长因子(VEGF)基因多态性(rs2010963)及其受体含激酶插入结构域受体(KDR)基因多态性(rs2071559)与2型糖尿病(T2DM)患者颈动脉粥样硬化标志物之间可能存在的关联。
患者与方法。纳入595例T2DM患者和200例对照者。采用超声检查评估颈动脉内膜中层厚度(CIMT)和斑块特征(存在情况和结构)。使用标准生化方法进行生化分析。采用竞争性等位基因特异性PCR(KASPar)分析对VEGF/KDR多态性(rs2010963、rs2071559)进行基因分型。
结果。糖尿病患者与对照者之间,VEGF/KDR多态性(rs2010963、rs2071559)的基因型分布和等位基因频率无统计学显著差异。在我们的研究中,我们证明了T2DM患者中KDR的rs2071559与CIMT或斑块厚度总和之间存在关联。然而,我们未证明VEGF的检测多态性(rs2010963)与CIMT、斑块厚度总和、受累节段数、超敏C反应蛋白(hsCRP)、颈动脉斑块的存在或不稳定颈动脉斑块的存在之间存在任何关联。
结论。在本研究中,我们证明了KDR的rs2071559对T2DM患者颈动脉粥样硬化标志物的影响较小。